← Leaderboards
Gloria M. Petersen
Johns Hopkins University
$29,119,396
Attributed
$37,204,989
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$71,448,844 · 14
By mechanism
P50$37,221,315 · 6
R01$21,381,542 · 3
U01$6,948,303 · 2
R25$4,397,684 · 1
P20$1,500,000 · 2
Top collaborators
- Kenneth S Zaret7 shared
- Santhi Swaroop Vege6 shared
- Martin Ernesto Fernandez-Zapico5 shared
- Barbara A. Koenig5 shared
- Hu Li5 shared
- Celine M Vachon5 shared
- Susan M Wolf5 shared
- Daniel D Billadeau4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Scott E Kern$10,982,210
- Alison P Klein$15,423,583
- Gregory D Kirk$60,349,977
- Ralph H Hruban$3,076,689
- David L Thomas$44,227,388
Others in their field
Top investigators on “Malignant Neoplasm Of Pancreas”
- David Heimbrook · Leidos Biomedical Research, Inc.$73,277,592
- Anirban Maitra · Johns Hopkins University$43,028,398
- Walter John Curran · Thomas Jefferson University$26,641,549
- Surinder Kumar Batra · University Of Pittsburgh At Pittsburgh$26,074,679
- Michael A Hollingsworth · University Of Nebraska Medical Center$23,837,917
- Robert E Reiter · University Of California Los Angeles$21,473,394
Research focus
Malignant Neoplasm Of PancreasClinicResourcesMalignant NeoplasmsResearch PersonnelFundingResearch InfrastructureResearch Project GrantsClinical ResearchEnsureDiagnosisBaseEvaluationCommunitiesBiometryMultidisciplinaryAdvisory CommitteesDesignTissuesEpidemiologyProgramsGeneticMeetingsTraining
Grant awards (89)
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$85,420
U01 · FY2022 · DK
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$811,268
U01 · FY2021 · CA · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$477,000
U01 · FY2021 · DK
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$93,810
U01 · FY2021 · DK
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$894,497
U01 · FY2020 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$590,577
R01 · FY2020 · CA · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$477,000
U01 · FY2020 · DK
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$120,000
U01 · FY2020 · DK
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$868,844
U01 · FY2019 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$583,253
R01 · FY2019 · CA · contact PI
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer$403,189
U01 · FY2019 · DK
Mayo Clinic SPORE in Pancreatic Cancer$2,297,971
P50 · FY2018 · CA · contact PI
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$936,650
U01 · FY2018 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$601,292
R01 · FY2018 · CA · contact PI
Clinical Research Core$259,864
P50 · FY2018 · CA · contact PI
Administrative Core$186,848
P50 · FY2018 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$64,301
R25 · FY2018 · CA
Mayo Clinic SPORE in Pancreatic Cancer$2,300,000
P50 · FY2017 · CA · contact PI
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$898,049
U01 · FY2017 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$590,577
R01 · FY2017 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$378,760
R25 · FY2017 · CA
Clinical Research Core$238,658
P50 · FY2017 · CA · contact PI
Administrative Core$189,674
P50 · FY2017 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,157,728
P50 · FY2016 · CA · contact PI
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$644,076
U01 · FY2016 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$578,620
R01 · FY2016 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$515,871
R25 · FY2016 · CA
Clinical Research Core$243,897
P50 · FY2016 · CA · contact PI
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$238,500
U01 · FY2016 · CA · contact PI
Administrative Core$175,422
P50 · FY2016 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,185,002
P50 · FY2015 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$469,757
R25 · FY2015 · CA
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment$452,960
R01 · FY2015 · CA · contact PI
Clinical Research Core$246,971
P50 · FY2015 · CA · contact PI
Administrative Core$177,636
P50 · FY2015 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,162,000
P50 · FY2014 · CA · contact PI
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment$583,293
R01 · FY2014 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$292,223
R25 · FY2014 · CA
Clinical Research Core$243,831
P50 · FY2014 · CA · contact PI
Administrative Core$175,372
P50 · FY2014 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$1,233,307
P50 · FY2013 · CA · contact PI
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment$546,546
R01 · FY2013 · CA · contact PI
CC: Clinical Research$184,057
P50 · FY2013 · CA · contact PI
CA: Administrative Core$121,714
P50 · FY2013 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,300,000
P50 · FY2012 · CA · contact PI
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)$1,520,860
R01 · FY2012 · CA · contact PI
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment$642,347
R01 · FY2012 · CA · contact PI
CC: Clinical Research$235,916
P50 · FY2012 · CA · contact PI
CA: Administrative Core$171,899
P50 · FY2012 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$9,696
R25 · FY2012 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,185,000
P50 · FY2011 · CA · contact PI
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)$1,530,169
R01 · FY2011 · CA · contact PI
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment$457,013
R01 · FY2011 · CA · contact PI
CC: Clinical Research$228,162
P50 · FY2011 · CA · contact PI
CA: Administrative Core$160,773
P50 · FY2011 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$149,911
R25 · FY2011 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,300,000
P50 · FY2010 · CA · contact PI
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)$1,934,190
R01 · FY2010 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$350,867
R25 · FY2010 · CA · contact PI
CC: Clinical Research$244,882
P50 · FY2010 · CA · contact PI
CA: Administrative Core$170,391
P50 · FY2010 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,300,000
P50 · FY2009 · CA · contact PI
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)$1,900,115
R01 · FY2009 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$353,167
R25 · FY2009 · CA · contact PI
CC: Clinical Research$238,263
P50 · FY2009 · CA · contact PI
CA: Administrative Core$171,536
P50 · FY2009 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,300,000
P50 · FY2008 · CA · contact PI
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)$1,705,171
R01 · FY2008 · CA · contact PI
Mayo Cancer Genetic Epidemiology Training Program$204,965
R25 · FY2008 · CA · contact PI
CC: Clinical Research$157,692
P50 · FY2008 · CA · contact PI
CA: Administrative Core$122,388
P50 · FY2008 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,179,546
P50 · FY2007 · CA · contact PI
Pancreatic Cancer Genetic Epidemiology Consortium$450,000
R01 · FY2007 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,244,641
P50 · FY2006 · CA · contact PI
Pancreatic Cancer Genetic Epidemiology Consortium$1,528,414
R01 · FY2006 · CA · contact PI
Mayo Clinic SPORE in Pancreatic Cancer$2,298,660
P50 · FY2005 · CA
Pancreatic Cancer Genetic Epidemiology Consortium$1,516,374
R01 · FY2005 · CA
Mayo Cancer Genetic Epidemiology Training Program$541,383
R25 · FY2005 · CA
Mayo Clinic SPORE in Pancreatic Cancer$2,300,000
P50 · FY2004 · CA
Pancreatic Cancer Genetic Epidemiology Consortium$1,472,082
R01 · FY2004 · CA
Mayo Cancer Genetic Epidemiology Training Program$536,646
R25 · FY2004 · CA
Mayo Clinic SPORE in Pancreatic Cancer$1,500,000
P20 · FY2003 · CA
Pancreatic Cancer Genetic Epidemiology Consortium$1,456,867
R01 · FY2003 · CA
Mayo Cancer Genetic Epidemiology Training Program$530,137
R25 · FY2003 · CA
Molecular epidemiology of pancreatic cancer$0
P20 · FY2003 · CA
Pancreatic Cancer Genetic Epidemiology Consortium$740,822
R01 · FY2002 · CA
FAMILY STUDIES OF LUNG CANCER$0
P50 · FY2002 · CA
FAMILY STUDIES OF LUNG CANCER$0
P50 · FY2001 · CA
FAMILY STUDIES OF LUNG CANCER$131,614
P50 · FY2000 · CA